全文获取类型
收费全文 | 1116篇 |
免费 | 64篇 |
出版年
2021年 | 20篇 |
2020年 | 11篇 |
2019年 | 15篇 |
2018年 | 26篇 |
2017年 | 17篇 |
2016年 | 33篇 |
2015年 | 48篇 |
2014年 | 49篇 |
2013年 | 64篇 |
2012年 | 102篇 |
2011年 | 75篇 |
2010年 | 48篇 |
2009年 | 48篇 |
2008年 | 60篇 |
2007年 | 44篇 |
2006年 | 61篇 |
2005年 | 44篇 |
2004年 | 42篇 |
2003年 | 28篇 |
2002年 | 43篇 |
2001年 | 20篇 |
2000年 | 12篇 |
1999年 | 12篇 |
1998年 | 7篇 |
1997年 | 4篇 |
1995年 | 10篇 |
1993年 | 7篇 |
1992年 | 8篇 |
1991年 | 8篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 8篇 |
1986年 | 7篇 |
1985年 | 8篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1978年 | 7篇 |
1971年 | 5篇 |
1970年 | 4篇 |
1965年 | 4篇 |
1958年 | 3篇 |
1956年 | 3篇 |
1936年 | 3篇 |
1929年 | 4篇 |
1928年 | 6篇 |
1919年 | 6篇 |
1918年 | 3篇 |
1913年 | 3篇 |
1851年 | 10篇 |
排序方式: 共有1180条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
George V. Sharonov Eduard V. Bocharov Peter M. Kolosov Maria V. Astapova Alexander S. Arseniev Alexey V. Feofanov 《The Journal of biological chemistry》2014,289(21):14955-14964
The EphA2 receptor tyrosine kinase plays a central role in the regulation of cell adhesion and guidance in many human tissues. The activation of EphA2 occurs after proper dimerization/oligomerization in the plasma membrane, which occurs with the participation of extracellular and cytoplasmic domains. Our study revealed that the isolated transmembrane domain (TMD) of EphA2 embedded into the lipid bicelle dimerized via the heptad repeat motif L535X3G539X2A542X3V546X2L549 rather than through the alternative glycine zipper motif A536X3G540X3G544 (typical for TMD dimerization in many proteins). To evaluate the significance of TMD interactions for full-length EphA2, we substituted key residues in the heptad repeat motif (HR variant: G539I, A542I, G553I) or in the glycine zipper motif (GZ variant: G540I, G544I) and expressed YFP-tagged EphA2 (WT, HR, and GZ variants) in HEK293T cells. Confocal microscopy revealed a similar distribution of all EphA2-YFP variants in cells. The expression of EphA2-YFP variants and their kinase activity (phosphorylation of Tyr588 and/or Tyr594) and ephrin-A3 binding were analyzed with flow cytometry on a single cell basis. Activation of any EphA2 variant is found to occur even without ephrin stimulation when the EphA2 content in cells is sufficiently high. Ephrin-A3 binding is not affected in mutant variants. Mutations in the TMD have a significant effect on EphA2 activity. Both ligand-dependent and ligand-independent activities are enhanced for the HR variant and reduced for the GZ variant compared with the WT. These findings allow us to suggest TMD dimerization switching between the heptad repeat and glycine zipper motifs, corresponding to inactive and active receptor states, respectively, as a mechanism underlying EphA2 signal transduction. 相似文献
5.
6.
Anna Pugatshova ülle Kikas Margit Prüssel Aivo Reinart Eduard Tamm et al. 《Plant Growth Regulation》1991,10(2):177-178
Book Review
Principles of environmental physicsJ.L. Monteith and M.H. Unsworth Second edition. London: Edward Arnold, 1990. xii + 291 pages. £30.00 (hardback), £14.95 (paperback). ISBN 0-7131-2931-X 相似文献7.
A M Batlle R E de Salamanca S Chinarro S G Afonso A M Stella 《The International journal of biochemistry》1986,18(2):143-147
The effects of light and porphyrins on the activity of red cell uroporphyrinogen decarboxylase were studied. Photoinactivation of uroporphyrinogen decarboxylase was dependent on uroporphyrin concentration, irradiation time and temperature. Using 40 W/m2 of UV light intensity, 40-45% decreased activity was produced with 200 microM uroporphyrin I, at 37 degrees C and after 2 hr of illumination. It has been demonstrated that porphyrins photoinactivate uroporphyrinogen decarboxylase and a mechanism for this action in relation to skin lesions is proposed. 相似文献
8.
Beneficial effect of S-adenosyl-L-methionine in lead intoxication. Another approach to clinical therapy 总被引:1,自引:0,他引:1
S R Paredes A A Juknat de Geralnik A M Batlle H A Conti 《The International journal of biochemistry》1985,17(5):625-629
Five patients with chronic lead intoxication were treated with S-adenosyl-L-methionine (12 mg/kg body weight, daily), given intravenously, over a period of 22 days. A significant recovery of erythrocytic ALA-D was observed in all cases, after therapy. Blood lead content significantly pathologic at the beginning of SAM administration, rapidly decreased within 24-48 h of initiating treatment, reaching nearly control values at the end of the trial. A good correlation between recovery of ALA-D activity and decreased concentration of lead in RBC was found. GSH content in blood was diminished in lead poisoned patients, increasing to normal levels after SAM administration. Other biochemical parameters such as Deaminase activity in RBC, ALA, PBG, porphyrins and lead in urine and serum gamma-GT were measured, showing no important deviations from control values before, during or after treatment. Both biochemical and clinical improvement was observed, indicating that SAM therapy is beneficial in the treatment of lead intoxication. No untoward signs were observed. The mechanism of action of SAM is not yet clear; however, a chelating effect could be excluded, and very likely its action can be attributed to glutathione availability. 相似文献
9.
10.